ELLIOT SIGAL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ELLIOT SIGAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ELLIOT SIGAL. ELLIOT SIGAL is CSO & President PRI in BRISTOL MYERS SQUIBB CO ($BMY) and EVP, CSO & President PRI in BRISTOL MYERS SQUIBB CO ($BMY) and EVP, CSO & President R&D in BRISTOL MYERS SQUIBB CO ($BMY) and SVP, Global Clin & Pharm Dev in BRISTOL MYERS SQUIBB CO ($BMY) and Director in Mead Johnson Nutrition Co ($MJN) and Director in Spark Therapeutics, Inc. ($ONCE).
Latest Insider Trading Transactions of ELLIOT SIGAL
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMY, MJN, ONCE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | U | 114.50 | 14,214 | 1,627,503 | 0 | 14.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | U | 114.50 | 14,214 | 1,627,503 | 0 | 14.2 K to 0 (-100.00 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,500 | 0 | 14,214 | 12.7 K to 14.2 K (+11.80 %) |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,500 | 0 | 12,714 | 11.2 K to 12.7 K (+13.38 %) |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,500 | 0 | 12,714 | 11.2 K to 12.7 K (+13.38 %) |
Apr 16 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | S | 72.43 | 29 | 2,100 | 11,214 | 11.2 K to 11.2 K (-0.26 %) |
Apr 16 2018 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | P | 90.75 | 29 | 2,632 | 11,243 | 11.2 K to 11.2 K (+0.26 %) |
Jun 15 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Option Exercise | D | 0.00 | 1,709 | 0 | 0 | |
Jun 15 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Sell | D | 90.00 | 5,180 | 466,200 | 0 | 5.2 K to 0 (-100.00 %) |
Jun 15 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Sell | D | 90.00 | 5,180 | 466,200 | 0 | 5.2 K to 0 (-100.00 %) |
Jun 15 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Sell | D | 90.00 | 2,590 | 233,100 | 0 | 2.6 K to 0 (-100.00 %) |
Jun 15 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Sell | D | 90.00 | 13,721 | 1,234,890 | 0 | 13.7 K to 0 (-100.00 %) |
Jun 02 2017 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
Jun 02 2017 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 50.93 | 4,000 | 203,720 | 4,000 | |
Mar 02 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 2,373 | 0 | 0 | |
Mar 02 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,709 | 0 | 1,709 | |
Mar 02 2017 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 2,373 | 0 | 13,721 | 11.3 K to 13.7 K (+20.91 %) |
Jun 03 2016 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | A | 56.22 | 6,000 | 337,320 | 6,000 | |
Mar 01 2016 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 2,373 | 0 | 2,373 | |
Mar 01 2016 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,678 | 0 | 0 | |
Mar 01 2016 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,678 | 0 | 11,348 | 9.7 K to 11.3 K (+17.35 %) |
Mar 03 2015 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 2,146 | 0 | 0 | |
Mar 03 2015 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 2,146 | 0 | 9,670 | 7.5 K to 9.7 K (+28.52 %) |
Feb 27 2015 | MJN | Mead Johnson Nutri ... | SIGAL ELLIOT | Director | Option Exercise | A | 0.00 | 1,678 | 0 | 1,678 | |
Mar 06 2008 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Option Exercise | A | 0.00 | 22,358 | 0 | 22,358 | |
Mar 06 2008 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Option Exercise | A | 22.14 | 305,909 | 6,772,825 | 305,909 | |
Mar 04 2008 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 22.61 | 925 | 20,914 | 165,493 | 166.4 K to 165.5 K (-0.56 %) |
Mar 04 2008 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 22.61 | 1,981 | 44,790 | 166,418 | 168.4 K to 166.4 K (-1.18 %) |
Nov 02 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 29.16 | 3,872 | 112,908 | 168,410 | 172.3 K to 168.4 K (-2.25 %) |
Sep 12 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 0.00 | 3,871 | 0 | 172,282 | 176.2 K to 172.3 K (-2.20 %) |
Mar 08 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Option Exercise | A | 27.01 | 20,625 | 557,081 | 20,625 | |
Mar 08 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Option Exercise | A | 27.01 | 244,500 | 6,603,945 | 244,500 | |
Mar 08 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 27.01 | 1,052 | 28,415 | 176,153 | 177.2 K to 176.2 K (-0.59 %) |
Mar 08 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Grant | A | 27.01 | 2,264 | 61,151 | 177,205 | 174.9 K to 177.2 K (+1.29 %) |
Mar 06 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 26.42 | 979 | 25,865 | 174,941 | 175.9 K to 174.9 K (-0.56 %) |
Mar 02 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 0.00 | 3,038 | 0 | 175,920 | 179 K to 175.9 K (-1.70 %) |
Feb 23 2007 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Payment of Exercise | F | 0.00 | 1,150 | 0 | 178,958 | 180.1 K to 179 K (-0.64 %) |
Dec 04 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | EVP, CSO & Presiden ... | Option Exercise | A | 24.74 | 300,000 | 7,422,000 | 300,000 | |
Nov 03 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Payment of Exercise | F | 24.76 | 3,038 | 75,221 | 180,108 | 183.1 K to 180.1 K (-1.66 %) |
Sep 12 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Payment of Exercise | F | 22.96 | 3,038 | 69,752 | 183,146 | 186.2 K to 183.1 K (-1.63 %) |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Option Exercise | A | 22.73 | 95,795 | 2,177,420 | 95,795 | |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Payment of Exercise | F | 22.73 | 1,862 | 42,323 | 186,184 | 188 K to 186.2 K (-0.99 %) |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Grant | A | 22.73 | 5,107 | 116,082 | 188,046 | 182.9 K to 188 K (+2.79 %) |
Mar 09 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Grant | A | 22.73 | 23,000 | 522,790 | 182,939 | 159.9 K to 182.9 K (+14.38 %) |
Mar 02 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Payment of Exercise | F | 22.94 | 3,871 | 88,801 | 159,939 | 163.8 K to 159.9 K (-2.36 %) |
Feb 22 2006 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Payment of Exercise | F | 23.09 | 1,466 | 33,850 | 163,810 | 165.3 K to 163.8 K (-0.89 %) |
Nov 02 2005 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Payment of Exercise | F | 21.12 | 3,871 | 81,756 | 165,276 | 169.1 K to 165.3 K (-2.29 %) |
Sep 21 2005 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | CSO & President PRI | Grant | A | 0.00 | 50,000 | 0 | 169,147 | 119.1 K to 169.1 K (+41.96 %) |
Mar 03 2005 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Option Exercise | A | 25.45 | 103,500 | 2,634,075 | 103,500 | |
Mar 03 2005 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Grant | A | 0.00 | 17,250 | 0 | 119,147 | 101.9 K to 119.1 K (+16.93 %) |
Mar 03 2005 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Payment of Exercise | F | 0.00 | 3,038 | 0 | 101,897 | 104.9 K to 101.9 K (-2.90 %) |
Feb 24 2005 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Payment of Exercise | F | 0.00 | 1,150 | 0 | 104,935 | 106.1 K to 104.9 K (-1.08 %) |
Aug 03 2004 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Payment of Exercise | F | 0.00 | 939 | 0 | 106,085 | 107 K to 106.1 K (-0.88 %) |
Mar 17 2004 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Option Exercise | A | 0.00 | 8,520 | 0 | 16,149 | |
Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Option Exercise | A | 28.11 | 48,333 | 1,358,641 | 48,333 | |
Mar 04 2004 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Grant | A | 0.00 | 8,056 | 0 | 107,024 | 99 K to 107 K (+8.14 %) |
Feb 23 2004 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Payment of Exercise | F | 28.41 | 1,056 | 30,001 | 98,968 | 100 K to 99 K (-1.06 %) |
Feb 23 2004 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Payment of Exercise | F | 28.41 | 1,056 | 30,001 | 98,968 | 100 K to 99 K (-1.06 %) |
Sep 12 2003 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Grant | A | 0.00 | 25,000 | 0 | 100,024 | 75 K to 100 K (+33.32 %) |
Aug 04 2003 | BMY | BRISTOL MYERS SQUI ... | SIGAL ELLIOT | SVP, Global Clin & ... | Payment of Exercise | F | 0.00 | 1,219 | 0 | 75,024 | 76.2 K to 75 K (-1.60 %) |
Page: 1